Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoyuki Naoi

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Pharmaceutical Development and Technology|April 25, 2018
The efficiency of lipid nanoparticles with an original cationic lipid as a siRNA delivery system for macrophages and dendritic cellsYasunori Uemura, Tomoyuki Naoi, Yasumasa Kanai, et al.
Journal of Pharmaceutical Sciences|January 24, 2007
Plasmid DNA uptake and subsequent cellular activation characteristics in human monocyte-derived cells in primary cultureYuga Fukuhara, Tomoyuki Naoi, Yoshiyuki Ogawa, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 26, 2009
Simultaneous delivery of doxorubicin and immunostimulatory CpG motif to tumors using a plasmid DNA/doxorubicin complex in miceYumiko Mizuno, Tomoyuki Naoi, Makiya Nishikawa, et al.
ACS Nano|March 16, 2021
Enhancing Inflammation Targeting Using Tunable Leukocyte-Based Biomimetic NanoparticlesAssaf Zinger, Manuela Sushnitha, Tomoyuki Naoi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 11, 2019
In vivo activation of PEGylated long circulating lipid nanoparticle to achieve efficient siRNA delivery and target gene knock down in solid tumorsYumi Sasayama, Maki Hasegawa, Eri Taguchi, et al.
ACS Applied Bio Materials|January 12, 2022
Reproducible and Characterized Method for Ponatinib Encapsulation into Biomimetic Lipid Nanoparticles as a Platform for Multi-Tyrosine Kinase-Targeted TherapyAssaf Zinger, Gherardo Baudo, Tomoyuki Naoi, et al.
Cancer Science|December 29, 2015
Tumor growth suppression by the combination of nanobubbles and ultrasoundRyo Suzuki, Yusuke Oda, Daiki Omata, et al.
ACS Medicinal Chemistry Letters|May 18, 2019
Simplifying the Chemical Structure of Cationic Lipids for siRNA-Lipid NanoparticlesTakeshi Kuboyama, Kaori Yagi, Tomoyuki Naoi, et al.
Circulation Research|October 25, 2019
Rapamycin-Loaded Biomimetic Nanoparticles Reverse Vascular InflammationChristian Boada, Assaf Zinger, Christopher Tsao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 12, 2021
Humanized Biomimetic Nanovesicles for Neuron TargetingAssaf Zinger, Caroline Cvetkovic, Manuela Sushnitha, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Pharmaceutical Development and Technology|April 25, 2018
The efficiency of lipid nanoparticles with an original cationic lipid as a siRNA delivery system for macrophages and dendritic cellsYasunori Uemura, Tomoyuki Naoi, Yasumasa Kanai, et al.
Journal of Pharmaceutical Sciences|January 24, 2007
Plasmid DNA uptake and subsequent cellular activation characteristics in human monocyte-derived cells in primary cultureYuga Fukuhara, Tomoyuki Naoi, Yoshiyuki Ogawa, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 26, 2009
Simultaneous delivery of doxorubicin and immunostimulatory CpG motif to tumors using a plasmid DNA/doxorubicin complex in miceYumiko Mizuno, Tomoyuki Naoi, Makiya Nishikawa, et al.
ACS Nano|March 16, 2021
Enhancing Inflammation Targeting Using Tunable Leukocyte-Based Biomimetic NanoparticlesAssaf Zinger, Manuela Sushnitha, Tomoyuki Naoi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 11, 2019
In vivo activation of PEGylated long circulating lipid nanoparticle to achieve efficient siRNA delivery and target gene knock down in solid tumorsYumi Sasayama, Maki Hasegawa, Eri Taguchi, et al.
ACS Applied Bio Materials|January 12, 2022
Reproducible and Characterized Method for Ponatinib Encapsulation into Biomimetic Lipid Nanoparticles as a Platform for Multi-Tyrosine Kinase-Targeted TherapyAssaf Zinger, Gherardo Baudo, Tomoyuki Naoi, et al.
Cancer Science|December 29, 2015
Tumor growth suppression by the combination of nanobubbles and ultrasoundRyo Suzuki, Yusuke Oda, Daiki Omata, et al.
ACS Medicinal Chemistry Letters|May 18, 2019
Simplifying the Chemical Structure of Cationic Lipids for siRNA-Lipid NanoparticlesTakeshi Kuboyama, Kaori Yagi, Tomoyuki Naoi, et al.
Circulation Research|October 25, 2019
Rapamycin-Loaded Biomimetic Nanoparticles Reverse Vascular InflammationChristian Boada, Assaf Zinger, Christopher Tsao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 12, 2021
Humanized Biomimetic Nanovesicles for Neuron TargetingAssaf Zinger, Caroline Cvetkovic, Manuela Sushnitha, et al.
Pageof 1